Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection.
Álvarez Bravo G, Ramió I Torrentà L. Álvarez Bravo G, et al. Among authors: ramio i torrenta l. Neurologia (Engl Ed). 2020 Nov-Dec;35(9):699-700. doi: 10.1016/j.nrl.2020.07.013. Epub 2020 Aug 3. Neurologia (Engl Ed). 2020. PMID: 32912742 Free PMC article. No abstract available.
Clinical heterogeneity in patients with myoclonus associated to COVID-19.
Álvarez Bravo G, Sánchez Cirera L, Angerri Nadal M, Ramió I Torrentà L. Álvarez Bravo G, et al. Among authors: ramio i torrenta l. Neurol Sci. 2022 Mar;43(3):1587-1592. doi: 10.1007/s10072-021-05802-1. Epub 2022 Jan 6. Neurol Sci. 2022. PMID: 34988717 Free PMC article.
[Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection].
Álvarez Bravo G, Ramió I Torrentà L. Álvarez Bravo G, et al. Among authors: ramio i torrenta l. Neurologia. 2020 Nov-Dec;35(9):699-700. doi: 10.1016/j.nrl.2020.07.013. Epub 2020 Aug 3. Neurologia. 2020. PMID: 38620290 Free PMC article. Spanish. No abstract available.
Calcitriol Treatment Is Safe and Increases Frataxin Levels in Friedreich Ataxia Patients.
Alemany-Perna B, Tamarit J, Cabiscol E, Delaspre F, Miguela A, Huertas-Pons JM, Quiroga-Varela A, Merchan Ruiz M, López Domínguez D, Ramió I Torrentà L, Genís D, Ros J. Alemany-Perna B, et al. Among authors: ramio i torrenta l. Mov Disord. 2024 Jul;39(7):1099-1108. doi: 10.1002/mds.29808. Epub 2024 May 2. Mov Disord. 2024. PMID: 38696306
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
Ramo-Tello C, Grau-López L, Tintoré M, Rovira A, Ramió i Torrenta L, Brieva L, Cano A, Carmona O, Saiz A, Torres F, Giner P, Nos C, Massuet A, Montalbán X, Martínez-Cáceres E, Costa J. Ramo-Tello C, et al. Among authors: ramio i torrenta l. Mult Scler. 2014 May;20(6):717-25. doi: 10.1177/1352458513508835. Epub 2013 Oct 21. Mult Scler. 2014. PMID: 24144876 Clinical Trial.
Adherence to interferon β-1b treatment in patients with multiple sclerosis in Spain.
Fernández O, Agüera E, Izquierdo G, Millán-Pascual J, Ramió I Torrentà L, Oliva P, Argente J, Berdei Y, Soler JM, Carmona O, Errea JM, Farrés J; Group on Adherence to IFNb-1b in Spain. Fernández O, et al. Among authors: ramio i torrenta l. PLoS One. 2012;7(5):e35600. doi: 10.1371/journal.pone.0035600. Epub 2012 May 16. PLoS One. 2012. PMID: 22615737 Free PMC article.